rosiglitazone has been researched along with Blood Clot in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capek, P; Ceska, R; Doležalová, R; Kasalová, Z; Marinov, I; Stulc, T; Svobodová, H | 1 |
| Atherton, RE; Gibbins, JM; Jones, CI; Kaiser, WJ; Moraes, LA; Sage, T; Spyridon, M | 1 |
2 other study(ies) available for rosiglitazone and Blood Clot
| Article | Year |
|---|---|
The effect of rosiglitazone on the expression of thrombogenic markers on leukocytes in type 2 diabetes mellitus.
Topics: Aged; Biomarkers; Blood Platelets; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Leukocytes; Male; Membrane Glycoproteins; Middle Aged; PPAR gamma; Receptors, Urokinase Plasminogen Activator; Rosiglitazone; Thiazolidinediones; Thrombosis | 2009 |
Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation.
Topics: Adaptor Proteins, Signal Transducing; Anilides; Animals; Blood Platelets; Calcium; Collagen; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Immunoblotting; Intracellular Signaling Peptides and Proteins; Ligands; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Phosphorylation; Platelet Aggregation; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Membrane Glycoproteins; PPAR gamma; Prostaglandin D2; Protein-Tyrosine Kinases; Rosiglitazone; Signal Transduction; Spectrometry, Fluorescence; Syk Kinase; Thiazolidinediones; Thrombosis; Time Factors; Tyrosine | 2010 |